Business Wire

Kinly Merges with Yorktel to Accelerate Global Growth and Expand Managed Services and Systems Integration Portfolios

12.8.2025 14:00:00 CEST | Business Wire | Press Release

Share

Yorktel, a New Jersey-based global AV systems integrator and managed services provider, today announced it has signed an agreement to combine with Kinly, a global AV and UCC integration firm headquartered in Amsterdam, to merge the two firms into a premier workplace experience and collaboration provider with unparalleled reach. This strategic merger will significantly accelerate global growth and expand next-generation systems integration capabilities with a larger talent base and portfolio of managed services and technology offerings.

The addition of Kinly’s operations, workforce, and client base will enhance Yorktel’s ability to meet the evolving needs of enterprise and public sector clients and provide a world-class customer experience across the globe. With complementary cultures and a shared commitment to service excellence, the planned integration strengthens Yorktel’s position as a trusted partner in digital workplace transformation while bringing additional capabilities and capacity to Kinly customers worldwide.

“This acquisition is an intentional step forward to grow with purpose and is an example of what is still to come as we pursue our strategy and deliver advanced solutions to our global clients,” said Ken Scaturro, CEO of Yorktel. “We are committed to leading the next wave of agentic transformation — simplifying operations, reducing complexity, and empowering organizations to work smarter all while improving the customer experience.”

“Merging with Yorktel marks an exciting next chapter for our team and customers,” said Tom Martin, CEO of Kinly. “Our organizations are aligned in values, strategy, and a relentless focus on delivering exceptional outcomes for our clients. Together, we will drive innovation, provide great opportunities to our employees and partners, and create even more value in a rapidly changing collaboration market.”

Together, the merged company will serve over 2,500 clients across 27 global locations, with more than 1,600 employees, including 900+ industry-specialist accreditations. This expanded scale elevates the ability to deliver truly global managed services, from on-site support and proactive monitoring to remote management, cloud voice, and AV lifecycle services, with greater consistency, capacity, and speed. Clients will benefit from broader geographic coverage, unified service operations, and an enhanced portfolio of AV, UCC, and UCaaS solutions, all backed by a commitment to ISO-certified security practices.

“We are proud to support the combination of Yorktel and Kinly, allowing both companies to be more relevant and valuable to their customers through their combined offerings in the continuously evolving AV space,” said Carlo Padovano, Partner at OEP. “Yorktel’s scaled North American and global footprint is perfectly complemented by Kinly’s extensive European base. Combined with their joint Asia Pacific capabilities, this creates unmatched global delivery,” added Otavio Birman, Principal at OEP.

The transaction is subject to customary regulatory and other approvals.

About Yorktel

With over 40 years of experience supporting Fortune Global 1000 companies and top government agencies, Yorktel is a trusted global systems integrator and managed services provider. As a founding pioneer of managed services in the video communications industry, we deliver AI-driven collaboration technology solutions, next-gen global integration, and holistic managed services to transform digital workplaces, optimize technology estates, maximize productivity, and reduce costs. For more information, visit www.yorktel.com.

About Kinly

Kinly is a leading AV and UCC systems integrator and the largest in Europe. It has over 25 years’ experience, and an international reach with 19 offices across EMEA, US and APAC.

Kinly specializes in complex AV integration, UCC, corporate communications, workspace management, corporate communications, events and managed services. From small installations to global digital transformations, Kinly collaborates with the world’s leading organizations to deliver their workplace ambitions with a unique and unrivalled service built on core pillars of innovation, security and quality, as well as a commitment to responsibly designed solutions. www.kinly.com

About One Equity Partners

One Equity Partners (“OEP”) is a middle market private equity firm focused on the industrial, healthcare, and technology sectors in North America and Europe. The firm seeks to build market-leading companies by identifying and executing transformative business combinations. OEP is a trusted partner with a differentiated investment process, a broad and senior team, and an established track record generating long-term value for its partners. Since 2001, the firm has completed more than 400 transactions worldwide. OEP, founded in 2001, spun out of JP Morgan in 2015. The firm has offices in New York, Chicago, Frankfurt and Amsterdam. For more information, please visit www.oneequity.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250811240768/en/

Contacts

Media
Thomas Zadvydas
646-502-3538
tzadvydas@stantonprm.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye